Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of active pharmaceutical ingredients and drug intermediates.
Arene Life Sciences Private Limited, is an unlisted private company incorporated on 17 September, 2004. It is classified as a private limited company and is located in Medak, Telangana. It's authorized share capital is INR 75.00 cr and the total paid-up capital is INR 37.40 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
The Karnataka Bank Limited
No. of Loans: 2
Total Amount : 56.4 cr
DBS BANK INDIA LIMITED
No. of Loans: 2
Total Amount : 34.1 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 31.7 cr
UCO Bank
No. of Loans: 1
Total Amount : 19.9 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 0.2 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Satyanarayana Reddy Khairtabad
Shareholder
|
01665330 | 20 years |
Director | Satyanarayana Reddy Chinnamail
Shareholder
|
01667950 | 20 years |
CFO | Satyanarayana Reddy Chinnamail | <HIDDEN> | 10 years |
Director | Khairtabad Anuraag Reddy | 07309379 | 5 years |
Director | Chinnamail Santosh Reddy | 08555868 | 5 years |
Kmp | Prachi Gupta | <HIDDEN> | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
M.M.FINE GRINDERS PRIVATE LIMITED |
Active
|
4.9 Cr | 2 | Telangana |
ARENE LIFE SCIENCES (UNIT 3) PRIVATE LIMITED |
Active
|
10.8 Cr | 4 | Telangana |
S.R. DRUGS AND INTERMEDIATES (UNIT 3) PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
S.R. DRUGS AND INTERMEDIATES (UNIT 2) PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
S.R. DRUGS AND INTERMEDIATES (UNIT 4) PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
ARENE LIFE SCIENCES (UNIT 4) PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
SRDUO INVESTMENTS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Telangana |
SRDUO INFRA LLP |
Active
|
1.0 L | 2 | Telangana |
S.R. DRUGS AND INTERMEDIATES PVT.LTD. |
Active
|
2.6 Cr | 2 | Telangana |
UNILOIDS SOLVENTS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
CHINNAMILE ORGANIC INDUSTRIES LLP |
Active
|
86.0 L | 1 | Telangana |
ANRISA FOODS LLP |
Active
|
1.0 L | 1 | Telangana |
KANAK RESOURCES MANAGEMENT PRIVATE LIMITED |
Active
|
12.9 Cr | 1 | Delhi |
The incorporation date of ARENE LIFE SCIENCES PRIVATE LIMITED is 17 September, 2004
The authorized share capital of ARENE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 75.0 Cr.
The paid-up capital of ARENE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 37.4 Cr.
The registered address of ARENE LIFE SCIENCES PRIVATE LIMITED is Plot No.49,50,209&210, Phase II IDA Pashamailaram Sangareddy Medak Telangana - 502307
The CIN number of ARENE LIFE SCIENCES PRIVATE LIMITED is U24239TG2004PTC044199.